New York City, NY -- (SBWIRE) -- 12/10/2013 -- StockMarketIntel.com issues a special report on the following stocks: Columbia Laboratories Inc. (NASDAQ:CBRX), LeapFrog Enterprises, Inc. (NYSE:LF), The Dow Chemical Company (NYSE:DOW), TherapeuticsMD Inc (NYSEMKT:TXMD)
Columbia Laboratories Inc. (NASDAQ:CBRX) declined -2.06%, trading on 137,741 shares, to end the trade at $6.67. The stock changed hands in a range of $6.50 to $6.82, bringing its market capitalization to about $80.10 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $4.46 and was moved to the maximum level of $8.37. Columbia Laboratories, Inc. (Columbia) is engaged in the business of developing, manufacturing and selling pharmaceutical products that utilize its bioadhesive drug delivery technologies to treat various medical conditions.
Why Should Investors Buy CBX After the Recent Fall? Just Go Here and Find Out
LeapFrog Enterprises, Inc. (NYSE:LF) added 0.93%, to complete the trading session at $8.65, with a total volume of 1.06 million shares. The stock, on average, trades on a volume of 2.32 million shares. It floated in a range of $8.57 to $8.77 during the last trading session, with a beta value of 2.22. Its market capitalization now moved to about $596.15 million. In the past 52 weeks, the share price has not declined below $7.40 and above $11.95. LeapFrog Enterprises, Inc. (LeapFrog) is a developer of educational entertainment for children. The Company’s product portfolio consists of multimedia learning platforms and related content and learning toys. The Company has developed a number of learning platforms, including the LeapPad Explorer (LeapPad) learning tablet, the Leapster family of multimedia learning platforms and the Tag and Tag Junior reading systems, which supports a library of content titles.
Will LF Continue To Move Higher? Find Out Here
The Dow Chemical Company (NYSE:DOW) recorded a gain of 3.90% and was in a range of $39.27-$40.81 before closing at $40.80. The stock completed the day with a total volume of 13.95 million shares, versus an average volume of 6.90 million shares. The share price hit its 52-week low of $29.55 and $41.74 was the best price. The Dow Chemical Company combines the power of science and technology to passionately innovate what is essential to human progress. The Company connects chemistry and innovation with the principles of sustainability to help address many of the problems, such as the need for clean water, renewable energy generation and conservation, and increasing agricultural productivity.
Why Should Investors Buy DOW After The Recent Gain? Just Go Here and Find Out
TherapeuticsMD Inc (NYSEMKT:TXMD) added 1.70% yesterday, bringing its market capitalization around $694.40 million. The share price, after opening at $4.80, made a high of $4.89 and hovered above $4.52 to end the day at $4.79. The total number of shares that changed hands during the session was 684,505 shares, as compared to average trading volume of 435,117 shares. TherapeuticsMD, Inc. promotes, distributes and sells certain products developed and sold by Spectrum Health Network, Inc. (Spectrum) relative to its digital media network. Through the license agreement, the Company focuses on multispecialty group practices and independent physician associations (IPAs) to sell them subscriptions for software, hardware and content developed for and distributed by Spectrum. Spectrum sells its network to IPAs for equipment and installation.
What was the Moving Force behind TXMD on Bullish Run? Read This Research Report
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)